TSE:MFC

Manulife Financial (MFC.TO)

61.42
+1.50 (2.50%)
as of Sep 3, 2026, 8:00:00 pm Market Open.
1632 watching
0
Investor Insights
star iconSep 3, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has garnered a mixture of opinions from analysts following its recent quarterly report, which showcased positive developments despite facing challenges such as a new tax on its products for mainland Chinese residents. The company is noted for its strong presence in Asia and steady growth in its wealth management segment, which remains a highlight in its long-term strategy. However, some experts express caution, labeling MFC as a bit overvalued relative to its earnings growth potential, currently trading over 2x book value. The financial landscape for insurers in Canada appears competitive, with both MFC and its peers like TD exhibiting relatively robust performance, yet the consensus leans toward a cautious approach due to market conditions. Overall, while MFC benefits from high dividends and solid asset management, uncertainties related to its exposure to market fluctuations warrant careful monitoring for potential entry points.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
BUY
Has gone nowhere for most of this year. The financials have been pretty disappointing. This one has international growth so it will always be his 1st choice, but Sun Life (SLF-T) is a nice complement because it has a different set of assets. You could buy both and do very well.
HOLD
Will be impacted by the malaise in the financial business. What is needed is the next leg up in the market where financials are leading the pack.
BUY ON WEAKNESS
Looking at this one very closely. Would like it a little bit cheaper. Good market diversification. The only near-term risk is if they did a major acquisition. Excellent management.
COMMENT
Stock has been dead for some time and she can't explain it. Numbers are good and they are executing well in the US.
BUY
Hasn't gone anywhere since November. Well-managed. Did a great acquisition with John Hancock. You'll have to be patient with this one. Solid value at this price.
WEAK BUY
He is nervous about the financial sector. However, he feels the insurance companies will do better than the banks. If you must be in the financial sector, this is one that you could hold. Watch that it doesn't go below its July low.
DON'T BUY
His model price has gone down a lot on this company. His model price is $38.23.
TOP PICK
A good example of a very well run company in terms of astuteness and capital management. Good global diversification.
COMMENT
Has been in a trading range of about $35 to $40 for some time. Financial services have generally been trending down, but that is more on the bank's side. Believes it will probably move up. Prefers Great West Life (GWO-T).
HOLD
Less sensitive to interest rates than the banks. Their ROE has stalled out. Doesn't expect it will do much in the next few months.
COMMENT
Management has done a tremendous job. Insurance companies in general are a little better priced than some of the banks. Good long-term Hold. Has been buying Sunlife (SLF-T) instead because the discount makes a slightly more attractive.
DON'T BUY
Long-term trend lines on most of the financials have been violated. Isn't looking for a collapse, but thinks the Up is over where the easy money has been made.
PAST TOP PICK
(A Top Pick July 4/06. Up 9.4%.) Having a very tough time getting over $41. Great management. Opening up 380 new sites in China next year.
BUY
Likes it. Has moved sideways the last little while. Has great global exposure, esp in Asia.
TOP PICK
Better growth profile than others. The John Hancock acquisition was a home run. Growth is coming from the US and Asia. Trading at a lower price earnings multiple than the banks. Less interest spread exposure.
Showing 1,786 to 1,800 of 2,284 entries